Details
| Stereochemistry | ACHIRAL |
| Molecular Formula | C7H5NS |
| Molecular Weight | 135.186 |
| Optical Activity | NONE |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
S1C=NC2=C1C=CC=C2
InChI
InChIKey=IOJUPLGTWVMSFF-UHFFFAOYSA-N
InChI=1S/C7H5NS/c1-2-4-7-6(3-1)8-5-9-7/h1-5H
| Molecular Formula | C7H5NS |
| Molecular Weight | 135.186 |
| Charge | 0 |
| Count |
|
| Stereochemistry | ACHIRAL |
| Additional Stereochemistry | No |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Optical Activity | NONE |
Approval Year
PubMed
| Title | Date | PubMed |
|---|---|---|
| Regioselectivity in the addition of vinylmagnesium bromide to heteroarylic ketones: C- versus O-alkylation. | 2004-12-10 |
|
| Fluorinated 2-(4-amino-3-methylphenyl)benzothiazoles induce CYP1A1 expression, become metabolized, and bind to macromolecules in sensitive human cancer cells. | 2004-12 |
|
| Activity of benzothiazoles and chemical derivatives on Plasmodium falciparum. | 2004-11 |
|
| [Investigation of the trichinellocidal activity of the agents from a series of benzthiazole and benzoxazole]. | 2004-10-16 |
|
| Synthesis and evaluation of antitumor activity of 2- and 6-[(1,3-benzothiazol-2-yl)aminomethyl]-5,8-dimethoxy-1,4-naphthoquinone derivatives. | 2004-09 |
|
| Inactivation of triosephosphate isomerase from Trypanosoma cruzi by an agent that perturbs its dimer interface. | 2004-08-27 |
|
| [A novel deprotonative functionalization of aromatics with phosphazene base]. | 2004-08 |
|
| Synthesis and antileishmanial activity of (1,3-benzothiazol-2-yl) amino-9-(10H)-acridinone derivatives. | 2004-08 |
|
| Density functional theory and ab initio studies of geometry, electronic structure and vibrational spectra of novel benzothiazole and benzotriazole herbicides. | 2004-08 |
|
| The efficiency of the benzothiazole APB, the echinocandin micafungin, and amphotericin B in fluconazole-resistant Candida albicans and Candida dubliniensis. | 2004-07 |
|
| Manipulation of alternative splicing by a newly developed inhibitor of Clks. | 2004-06-04 |
|
| A fission yeast strain expressing human CDC25A phosphatase: a tool for selectivity studies of pharmacological inhibitors of CDC25. | 2004-05 |
|
| Some fused heterocyclic compounds as eukaryotic topoisomerase II inhibitors. | 2004-04-30 |
|
| Inhibitory activities against topoisomerase I and II by polyhydroxybenzoyl amide derivatives and their structure-activity relationship. | 2004-04-05 |
|
| Synthesis, crystal structure and antiproliferative evaluation of some new substituted benzothiazoles and styrylbenzothiazoles. | 2004-04 |
|
| Synthesis and SAR of 2-arylbenzoxazoles, benzothiazoles and benzimidazoles as inhibitors of lysophosphatidic acid acyltransferase-beta. | 2004-03-22 |
|
| Synthesis and structure-activity relationships of new antimicrobial active multisubstituted benzazole derivatives. | 2004-03 |
|
| Evolution of beetle bioluminescence: the origin of beetle luciferin. | 2004-02-26 |
|
| Zapoteca formosa: sulfur chemistry and phytotoxicity. | 2004-02 |
|
| Strong protective action of Copper(II) N-substituted sulfonamide complexes against reactive oxygen species. | 2004-02 |
|
| Occurrence of benzothiazoles in municipal wastewater and their fate in biological treatment. | 2004 |
|
| Development of a PET/SPECT agent for amyloid imaging in Alzheimer's disease. | 2004 |
|
| Effects of coffee components on the response of GABA(A) receptors expressed in Xenopus oocytes. | 2003-12-17 |
|
| Iodinated tracers for imaging amyloid plaques in the brain. | 2003-12-12 |
|
| Synthesis and biological evaluation of benzo[d]isothiazole, benzothiazole and thiazole Schiff bases. | 2003-11-03 |
|
| Discovery of novel benzothiazolesulfonamides as potent inhibitors of HIV-1 protease. | 2003-11-03 |
|
| A new approach to the synthesis of benzothiazole, benzoxazole, and pyridine nucleosides as potential antitumor agents. | 2003-11 |
|
| Design and synthesis of pyrrolidine-5,5'-trans-lactams (5-oxo-hexahydropyrrolo[3,2-b]pyrroles) as novel mechanism-based inhibitors of human cytomegalovirus protease. 4. Antiviral activity and plasma stability. | 2003-10-09 |
|
| Synthesis and PDF inhibitory activities of novel benzothiazolylidenehydroxamic acid derivatives. | 2003-10-06 |
|
| Cobalt-catalyzed arylation of azole heteroarenes via direct C-H bond functionalization. | 2003-10-02 |
|
| 2-Amino-1,3-benzothiazole-ethyl coumarin-3-carboxylate (1/1). | 2003-10 |
|
| ACD6, a novel ankyrin protein, is a regulator and an effector of salicylic acid signaling in the Arabidopsis defense response. | 2003-10 |
|
| PMHS-mediated couplings of alkynes or benzothiazoles with various electrophiles: application to the synthesis of (-)-akolactone A. | 2003-08-22 |
|
| Discovery of 2-amino-heteroaryl-benzothiazole-6-anilides as potent p56(lck) inhibitors. | 2003-08-04 |
|
| Synthesis of some new benzothiazole derivatives as potential antimicrobial and antiparasitic agents. | 2003-08 |
|
| Application of thin-layer chromatographic data in quantitative structure-activity relationship assay of thiazole and benzothiazole derivatives with H1-antihistamine activity. II. | 2003-07-25 |
|
| Application of thin-layer chromatographic data in quantitative structure-activity relationship assay of thiazole and benzothiazole derivatives with H1-antihistamine activity. I. | 2003-07-25 |
|
| Molecular design, synthesis, and structure-Activity relationships leading to the potent and selective p56(lck) inhibitor BMS-243117. | 2003-07-07 |
|
| Assessment of occupational health hazards in scrap-tire shredding facilities. | 2003-06-20 |
|
| Zinc complexes of benzothiazole-derived Schiff bases with antibacterial activity. | 2003-06 |
|
| Structure-activity relationships of 2-(benzothiazolylthio)acetamide class of CCR3 selective antagonist. | 2003-06 |
|
| Stereoselective synthesis of tetrasubstituted 2,3-dihydrofurans by one-step cyclization of beta-ketosulfides of benzothiazole and aldehydes in ionic liquids. | 2003-05-30 |
|
| Inhibition of UV-induced mutagenesis in Euglena gracilis by benzothiazole derivatives. | 2003-05 |
|
| Antitumor benzothiazoles. Frontier molecular orbital analysis predicts bioactivation of 2-(4-aminophenyl)benzothiazoles to reactive intermediates by cytochrome P4501A1. | 2003-02-07 |
|
| Kinetic study of reactions between ozone and benzothiazole in water. | 2003 |
|
| Mining the NCI screening database: explorations of agents involved in cell cycle regulation. | 2003 |
|
| Environmental impact of highway construction and repair materials on surface and ground waters. Case study: crumb rubber asphalt concrete. | 2003 |
|
| Effects of lipophilicity on the affinity and nonspecific binding of iodinated benzothiazole derivatives. | 2003 |
|
| Synthesis and HIV-1 reverse transcriptase inhibitor activity of some 2,5,6-substituted benzoxazole, benzimidazole, benzothiazole and oxazolo(4,5-b)pyridine derivatives. | 2003 |
|
| Glucose analog inhibitors of glycogen phosphorylases as potential antidiabetic agents: recent developments. | 2003 |
Patents
| Substance Class |
Chemical
Created
by
admin
on
Edited
Mon Mar 31 18:47:20 GMT 2025
by
admin
on
Mon Mar 31 18:47:20 GMT 2025
|
| Record UNII |
G5BW2593EP
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Preferred Name | English | ||
|
Systematic Name | English | ||
|
Code | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
| Classification Tree | Code System | Code | ||
|---|---|---|---|---|
|
JECFA EVALUATION |
BENZOTHIAZOLE
Created by
admin on Mon Mar 31 18:47:20 GMT 2025 , Edited by admin on Mon Mar 31 18:47:20 GMT 2025
|
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
95-16-9
Created by
admin on Mon Mar 31 18:47:20 GMT 2025 , Edited by admin on Mon Mar 31 18:47:20 GMT 2025
|
PRIMARY | |||
|
7222
Created by
admin on Mon Mar 31 18:47:20 GMT 2025 , Edited by admin on Mon Mar 31 18:47:20 GMT 2025
|
PRIMARY | |||
|
SUB32860
Created by
admin on Mon Mar 31 18:47:20 GMT 2025 , Edited by admin on Mon Mar 31 18:47:20 GMT 2025
|
PRIMARY | |||
|
202-396-2
Created by
admin on Mon Mar 31 18:47:20 GMT 2025 , Edited by admin on Mon Mar 31 18:47:20 GMT 2025
|
PRIMARY | |||
|
8040
Created by
admin on Mon Mar 31 18:47:20 GMT 2025 , Edited by admin on Mon Mar 31 18:47:20 GMT 2025
|
PRIMARY | |||
|
100000126226
Created by
admin on Mon Mar 31 18:47:20 GMT 2025 , Edited by admin on Mon Mar 31 18:47:20 GMT 2025
|
PRIMARY | |||
|
DTXSID7024586
Created by
admin on Mon Mar 31 18:47:20 GMT 2025 , Edited by admin on Mon Mar 31 18:47:20 GMT 2025
|
PRIMARY | |||
|
m2380
Created by
admin on Mon Mar 31 18:47:20 GMT 2025 , Edited by admin on Mon Mar 31 18:47:20 GMT 2025
|
PRIMARY | Merck Index | ||
|
45993
Created by
admin on Mon Mar 31 18:47:20 GMT 2025 , Edited by admin on Mon Mar 31 18:47:20 GMT 2025
|
PRIMARY | |||
|
G5BW2593EP
Created by
admin on Mon Mar 31 18:47:20 GMT 2025 , Edited by admin on Mon Mar 31 18:47:20 GMT 2025
|
PRIMARY | |||
|
2796
Created by
admin on Mon Mar 31 18:47:20 GMT 2025 , Edited by admin on Mon Mar 31 18:47:20 GMT 2025
|
PRIMARY | |||
|
973
Created by
admin on Mon Mar 31 18:47:20 GMT 2025 , Edited by admin on Mon Mar 31 18:47:20 GMT 2025
|
PRIMARY | |||
|
BENZOTHIAZOLE
Created by
admin on Mon Mar 31 18:47:20 GMT 2025 , Edited by admin on Mon Mar 31 18:47:20 GMT 2025
|
PRIMARY |